Osteosarcoma lung metastases detection and principles of multimodal therapy
- PMID: 20213390
- DOI: 10.1007/978-1-4419-0284-9_8
Osteosarcoma lung metastases detection and principles of multimodal therapy
Abstract
The management of pulmonary metastases poses a challenge to the multidisciplinary team involved in the treatment of osteosarcoma. A postal survey on the management of pulmonary metastases in osteosarcoma involving 17 representatives from international study groups and selected institutions was performed in which a response rate of 94% was achieved. The results showed uniform approaches in areas like the imaging methods used for initial staging and the use of manual exploration with thoracotomy. However, it demonstrated diverse practices regarding exploration of the unaffected site in unilateral pulmonary disease, and the approach to lesions disappearing under chemotherapy. Furthermore, agreement on the size of a lesion considered to distinguish between benign and of metastatic origin, varied. Based on the survey and a review of the current literature, detection methods and principles of multimodal therapy will be discussed. Prognostic factors in synchronous and metachronous pulmonary metastases and their implications for a multimodal therapy is also presented.
Similar articles
-
The role of thoracic surgery in the management of metastatic osteogenic sarcoma.Chest Surg Clin N Am. 1994 Feb;4(1):75-83. Chest Surg Clin N Am. 1994. PMID: 8055286
-
Multimodal treatment of osteosarcoma lung metastases.Thorac Cardiovasc Surg. 2006 Aug;54(5):328-31. doi: 10.1055/s-2006-923918. Thorac Cardiovasc Surg. 2006. PMID: 16902881
-
Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.Cancer. 2004 May 1;100(9):1936-42. doi: 10.1002/cncr.20151. Cancer. 2004. PMID: 15112275
-
Management of osteosarcoma pulmonary metastases.Semin Pediatr Surg. 2006 Feb;15(1):25-9. doi: 10.1053/j.sempedsurg.2005.11.005. Semin Pediatr Surg. 2006. PMID: 16458843 Review.
-
Non-surgical treatment of pulmonary and extra-pulmonary metastases.Cancer Treat Res. 2009;152:203-15. doi: 10.1007/978-1-4419-0284-9_10. Cancer Treat Res. 2009. PMID: 20213392 Review.
Cited by
-
Predictors of pulmonary metastases on chest computed tomography in children and adolescents with osteosarcoma-tips for qualifying patients for thoracotomy.BMC Pediatr. 2024 Jun 3;24(1):382. doi: 10.1186/s12887-024-04858-0. BMC Pediatr. 2024. PMID: 38831258 Free PMC article.
-
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial).BMC Cancer. 2022 Jun 8;22(1):629. doi: 10.1186/s12885-022-09697-9. BMC Cancer. 2022. PMID: 35672690 Free PMC article. Clinical Trial.
-
SIRT2 promotes the viability, invasion and metastasis of osteosarcoma cells by inhibiting the degradation of Snail.Cell Death Dis. 2022 Nov 7;13(11):935. doi: 10.1038/s41419-022-05388-2. Cell Death Dis. 2022. PMID: 36344502 Free PMC article.
-
Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.Sarcoma. 2015;2015:516843. doi: 10.1155/2015/516843. Epub 2015 Feb 17. Sarcoma. 2015. PMID: 25784831 Free PMC article.
-
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.Nat Commun. 2023 Jun 8;14(1):3375. doi: 10.1038/s41467-023-39097-x. Nat Commun. 2023. PMID: 37291203 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical